Uncovering Tumorigenesis Circuitry with Combinatorial CRISPR

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Cancer development involves alterations in multiple driver genes, but the specific combinations promoting oncogenesis remain unclear.
• Understanding gene interactions is crucial for deciphering complex cancer networks and developing targeted therapies.

Purpose of the Study:

• To systematically identify synergistic interactions among tumor suppressor genes using a high-throughput CRISPR-Cas9 screening approach.
• To map the complex genetic networks that collaborate to drive tumorigenesis.

Main Methods:

• Utilized CRISPR-Cas9 gene editing to perform pairwise knockouts of 52 tumor suppressor genes across various cancer models.
• Conducted interaction screens in both cell cultures and mouse models to identify cooperating gene alterations.
• Employed single-cell transcriptomic profiling to characterize synergistic gene interactions in detail.

Main Results:

• Identified significant cooperation among NF2, PTEN, and TP53 genes in promoting cell growth across multiple tumorigenesis models.
• Revealed other strongly synergistic interactions between tumor suppressor genes.
• Demonstrated the scalability of the CRISPR-based screening approach for mapping gene networks.

Conclusions:

• The study presents a scalable methodology to move beyond single-gene drivers and map complex gene networks in cancer.
• The findings highlight the collaborative roles of specific tumor suppressor genes, such as NF2, PTEN, and TP53, in oncogenesis.
• This approach provides a foundation for understanding combinatorial gene alterations in cancer development.